Hess Shmuel
Known title: COO & Chief Commercial OfficerCIK: 0002085305
Associated companies
Transaction History
| MDWD | ▼ Sell | Open Market | 1,979 | $25K | 8/27/2026 | View on chart |
| MDWD | ▼ Sell | Open Market | 1,979 | $26K | 8/27/2026 | View on chart |
| MDWD | ▼ Sell | Open Market | 1,865 | $24K | 8/26/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
MediWound Secures $3.3M U.S. Department of War Grant
MediWound has been awarded an additional $3.3 million by the U.S. Department of War. The funding is intended to advance the development of a room-temperature-stable formulation of its NexoBrid product. This grant supports the company's ongoing research efforts for its lead therapeutic asset.
MediWound Secures $3.3M U.S. Department of War Grant. MediWound has been awarded an additional $3.3 million by the U.S. Department of War. The funding is intended to advance the development of a room-temperature-stable formulation of its NexoBrid product. This grant supports the company's ongoing research efforts for its lead therapeutic asset.